SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-067397
Filing Date
2018-11-09
Accepted
2018-11-09 16:11:35
Documents
13
Period of Report
2018-11-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-39950_18k.htm 8-K 23653
2 EX-99.1 a18-39950_1ex99d1.htm EX-99.1 33272
3 EX-99.2 a18-39950_1ex99d2.htm EX-99.2 14893
4 GRAPHIC g399501mm01i001.jpg GRAPHIC 6866
5 GRAPHIC g399501moi001.gif GRAPHIC 36621
6 GRAPHIC g399501moi002.gif GRAPHIC 145619
7 GRAPHIC g399501moi003.gif GRAPHIC 44571
8 GRAPHIC g399501moi004.gif GRAPHIC 59669
9 GRAPHIC g399501moi005.gif GRAPHIC 71109
10 GRAPHIC g399501moi006.gif GRAPHIC 76571
11 GRAPHIC g399501moi007.gif GRAPHIC 43257
12 GRAPHIC g399501moi008.gif GRAPHIC 96987
13 GRAPHIC g399501moi009.gif GRAPHIC 55218
  Complete submission text file 0001104659-18-067397.txt   950815
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 181173207
SIC: 2834 Pharmaceutical Preparations